Common questions about Регулакс (FAQ)
Q: Is there a risk of dependence or 'withdrawal syndrome' when using Регулакс?
Official information indicates that taking stimulant laxatives for longer than a brief period of treatment may lead to impaired function of the intestine and dependence on laxatives. This risk is the basis for the regulatory constraint defining the duration of use as strictly short-term.
Q: Is Регулакс allowed for use during pregnancy?
Regulatory documents state that use during pregnancy is generally not recommended and should be avoided. Consultation with a health professional is advised to determine if use is appropriate in individual circumstances.
Q: What are the restrictions on using Регулакс during breastfeeding (lactation)?
Official information indicates that small amounts of the medicine’s metabolites may pass into breast milk. Use during lactation is generally not recommended or should be avoided unless a doctor has advised its use.
Q: Can Регулакс disturb the water and electrolyte balance in the body?
Prolonged use or misuse of the medication may lead to disturbances in fluid and electrolyte balance, specifically hypokalaemia (low potassium levels). This risk is the basis for the regulatory constraint defining the duration of use as strictly short-term.
Q: Is it true that Регулакс can be taken for diabetes?
The specific composition of the product, including non-active ingredients (excipients), must be checked against the official product label. Some liquid formulations of Regulax contain sorbitol, and this requires confirmation against the specific patient’s condition and the product label. The exact composition details are found in the official documents.
Q: Is it true that long-term use of Регулакс can cause atony of the intestine?
Long-term use of stimulant laxatives may be associated with impaired function of the intestine, sometimes resulting in a loss of normal muscle tone, known as an atonic colon. This adverse outcome is documented in regulatory safety profiles.
Q: Can adrenal cortex hormones increase the risk of hypokalaemia when taking Регулакс?
Yes, regulatory documents list corticosteroids (a type of adrenal cortex hormone) as a medicine that interacts with sennosides. Taking this combination may increase the risk of hypokalaemia, which is an electrolyte imbalance.
Q: Is the effectiveness of Регулакс related to the level of the active metabolite in the blood?
Official pharmacological information indicates that the therapeutic action of sennosides is specific to the colon (large intestine). The product’s effect is independent of systemic absorption into the bloodstream.
Q: What should I do if Регулакс has not started working after 12 hours?
Regulatory instructions define the expected effect to occur within 6 to 12 hours. If no bowel action has occurred after a set period, or if symptoms persist, official guidance advises seeking professional medical advice.
Q: Can Регулакс be used for preparation for medical procedures?
Research has examined the use of sennosides as part of a regimen for preparing the colon before certain diagnostic procedures. However, this specific use may not be listed as an authorized indication on all official product labels.
Q: Do I need to drink water with Регулакс drops, or can I take them as is?
Specific instructions for the liquid drop formulation, such as taking them with or without water, are detailed in the product’s Patient Information Leaflet. The precise method of administration is detailed in the official instructions and should be respected.
Q: Why is sorbitol included in the composition of Регулакс drops?
Sorbitol is listed as an excipient (a non-active ingredient) in some liquid formulations of Regulax. In pharmaceutical preparations, such components are often included to act as a sweetener, solvent, or stabilizer, as detailed in the official composition documents.
Q: Can Регулакс cause an allergic reaction?
Hypersensitivity (allergy) to the active substance or any non-active ingredients is listed as a contraindication in official documents. Hypersensitivity reactions affecting the skin have also been reported as possible undesirable effects.
Q: Is Регулакс allowed for patients with hemorrhoids or anal fissures?
Sennosides are used in clinical practice to soften stool and reduce straining during defecation in patients with these conditions. However, this specific usage may not be listed as an official indication on all product labels.
Q: Does Регулакс have side effects related to the nervous system?
While the main side effects are gastrointestinal, regulatory listings mention that nervous system effects, such as confusion or dizziness, may occur. These are usually documented in cases associated with severe fluid and electrolyte imbalance caused by misuse.
Q: Does Регулакс help with constipation caused by taking other medications?
Research has explored the use of sennosides in specific contexts, such as when temporary bowel irregularity is associated with taking other necessary medications. For example, studies have examined its use in patients experiencing constipation related to opioid medication use.
Q: Can Регулакс drops be added to food or drinks?
The official product instructions for the method of administration are provided for the liquid solution. Altering the administration by adding the drops to food or unauthorized liquids is not described in the regulatory guidance.
Q: Is there a risk of Регулакс overdose and what are its symptoms?
Yes, an overdose is possible. Official regulatory information documents the major symptoms of overdose as severe cramping pain and intense diarrhea, which can lead to significant loss of fluid and electrolytes, specifically potassium depletion.
Q: Does Регулакс contain gluten?
Information regarding the presence of gluten must be determined by reviewing the excipients (non-active ingredients) listed in the specific product’s Summary of Product Characteristics or Patient Information Leaflet. This detail is found in the official composition documents.
Q: Can Регулакс be taken if there is already severe dehydration?
No, regulatory documents strictly state that the use of sennosides is absolutely prohibited in individuals who already have a severe dehydration state involving water and electrolyte depletion.
Q: Can Регулакс be taken if the cause of constipation is unknown?
Official product information contraindicates (prohibits) the product’s use in cases of undiagnosed acute or persistent gastrointestinal complaints, particularly abdominal pain of unknown origin.
Q: Does Регулакс affect the ability to drive a car or operate machinery?
The Summary of Product Characteristics (SmPC) for senna-containing products generally states that there is no known effect on the ability to drive or use heavy machinery.
Q: Does Регулакс affect the intestinal microflora?
The product’s mechanism of action is dependent on the colonic microflora (bacteria in the large intestine), which is necessary to metabolize the parent molecule into its active substance. The effect on the microflora is not typically detailed in regulatory documents.
Q: How often can the course of Регулакс be repeated?
The course of treatment is strictly defined as short-term, typically not to exceed one week. While the frequency for repeating short-term courses is not explicitly defined in the general regulatory text, using the product for more than 1–2 weeks requires medical supervision.
Q: Can Регулакс be used for irritable bowel syndrome (IBS) with predominant constipation?
Official warnings prohibit the use of the medicine in patients with acute inflammatory bowel diseases. Irritable Bowel Syndrome (IBS) is a separate condition that has been the subject of some research regarding senna use, but it is not listed as an official indication.
Q: Are there storage restrictions for Регулакс after opening the bottle?
The general regulatory text covers storage conditions for the unopened product. The stability or post-opening shelf life of the liquid formulation, if applicable, would be specifically detailed in the product's full Patient Information Leaflet.
Q: Can Регулакс cause a rash or skin itching?
Yes, adverse reactions affecting the skin have been documented in official safety profiles. These include pruritus (itching), urticaria (hives), and exanthema (a rash).
Q: Is it true that Регулакс helps with postpartum constipation?
Clinical practice summaries suggest that senna may be used to manage constipation in the puerperium (postpartum period), though medical advice is required if breastfeeding. This is based on general clinical patterns rather than a specific official postpartum indication.
Q: What is the mechanism of action of the sennosides contained in Регулакс fruit cubes?
The product's function begins when sennosides are converted by colonic bacteria into the active substance, which then stimulates the muscle contractions of the colon and helps reduce water reabsorption to facilitate bowel movements.
Q: Does Регулакс affect the absorption of nutrients from food?
The acceleration of intestinal transit is documented to reduce the absorption of co-administered oral medications. Regulatory documents do not generally contain specific data on the absorption of general food nutrients.
Q: Can Регулакс be used for chronic constipation?
The medicine is officially indicated for the short-term relief of occasional constipation. Its use is limited to a maximum of one week unless there is medical supervision, and it is not intended for the management of chronic conditions.
Q: What will happen if I take Регулакс in the morning instead of the evening?
Official regulatory documents advise taking the dose at bedtime to ensure the expected effect occurs within the 6 to 12 hour timeframe. Taking the medicine at a time other than bedtime is expected to shift the 6 to 12 hour timeframe for the desired effect, which may then occur during the day.
Q: What other components besides senna are included in Регулакс fruit cubes?
The specific components (excipients) of the fruit cube formulation are listed in the product’s Summary of Product Characteristics (SmPC) or Patient Information Leaflet, which are the official regulatory sources for ingredient information.
Q: Why do Регулакс fruit cubes have a dark brown color?
Official regulatory documents describe the appearance of the dosage form. The dark brown color is a result of the formulation process and the natural, botanical origin of the active ingredient, Senna.
Q: How quickly should natural bowel functions return to normal after stopping Регулакс?
Official information indicates that once regularity has been regained, the dosage should be reduced and the medication can usually be stopped. The documentation does not specify a precise timeframe for a complete return to natural function after cessation.
